BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15203143)

  • 1. Synthesis and antiangiogenic activity of exo-olefinated deoxoartemisinin derivatives.
    Oh S; Jeong IH; Shin WS; Lee S
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3683-6. PubMed ID: 15203143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient synthesis of exo-olefinated deoxoartemisinin derivatives by Ramberg-Bäcklund rearrangement.
    Oh S; Jeong IH; Lee S
    J Org Chem; 2004 Feb; 69(3):984-6. PubMed ID: 14750835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
    Jung M; Tak J; Chung WY; Park KK
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives.
    Oh S; Jeong IH; Ahn CM; Shin WS; Lee S
    Bioorg Med Chem; 2004 Jul; 12(14):3783-90. PubMed ID: 15210144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol.
    Jeong BS; Choi NS; Ahn SK; Bae H; Kim HS; Kim D
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3580-3. PubMed ID: 15978809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticancer activity of novel amide derivatives of non-acetal deoxoartemisinin.
    Jung M; Park N; Moon HI; Lee Y; Chung WY; Park KK
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6303-6. PubMed ID: 19819696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
    Jung M; Lee S; Ham J; Lee K; Kim H; Kim SK
    J Med Chem; 2003 Mar; 46(6):987-94. PubMed ID: 12620075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of symmetrical bis-alkynyl or alkyl pyridine and thiophene derivatives and their antiangiogenic activities.
    Ahn CM; Shin WS; Bum Woo H; Lee S; Lee HW
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3893-6. PubMed ID: 15225692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First synthesis of 10 alpha-(trifluoromethyl)deoxoartemisinin.
    Chorki F; Grellepois F; Crousse B; Hoang VD; Hung NV; Bonnet-Delpon D; Bégué JP
    Org Lett; 2002 Mar; 4(5):757-9. PubMed ID: 11869120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold(III) Salen complex-catalyzed synthesis of propargylamines via a three-component coupling reaction.
    Lo VK; Liu Y; Wong MK; Che CM
    Org Lett; 2006 Apr; 8(8):1529-32. PubMed ID: 16597102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxylation of 10-deoxoartemisinin by Cunninghamella elegans.
    Parshikov IA; Muraleedharan KM; Miriyala B; Avery MA; Williamson JS
    J Nat Prod; 2004 Sep; 67(9):1595-7. PubMed ID: 15387669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
    Zhou G; Tsai CW; Liu JO
    J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
    Lu J; Chong CR; Hu X; Liu JO
    J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell.
    Huan-huan C; Li-Li Y; Shang-Bin L
    Cancer Lett; 2004 Aug; 211(2):163-73. PubMed ID: 15219940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation-activity relationship on novel 4-pyridylmethylthio derivatives with antiangiogenic activity.
    Honda T; Tajima H; Kaneko Y; Ban M; Inaba T; Takeno Y; Okamoto K; Aono H
    Bioorg Med Chem Lett; 2008 May; 18(9):2939-43. PubMed ID: 18420406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.
    Chen HH; Zhou HJ; Fang X
    Pharmacol Res; 2003 Sep; 48(3):231-6. PubMed ID: 12860439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis inhibitors derived from thalidomide.
    Noguchi T; Fujimoto H; Sano H; Miyajima A; Miyachi H; Hashimoto Y
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5509-13. PubMed ID: 16183272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin.
    Njardarson JT; Gaul C; Shan D; Huang XY; Danishefsky SJ
    J Am Chem Soc; 2004 Feb; 126(4):1038-40. PubMed ID: 14746469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, discovery and preliminary SAR study of benzofuran derivatives as angiogenesis inhibitors.
    Chen Y; Chen S; Lu X; Cheng H; Ou Y; Cheng H; Zhou GC
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1851-4. PubMed ID: 19272775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the synthesis of antiangiogenic (+)-coronarin A and congeners from (+)-sclareolide.
    Oh S; Jeong IH; Shin WS; Lee S
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2009-12. PubMed ID: 12781184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.